Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aytu Biopharma Inc (NQ: AYTU ) 2.440 -0.030 (-1.21%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Aytu Biopharma Inc < Previous 1 2 3 4 Next > Sidoti Events, LLC's Virtual August Micro-Cap Conference August 13, 2024 Via ACCESSWIRE Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024 August 08, 2024 Via ACCESSWIRE Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations August 06, 2024 Via ACCESSWIRE Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms June 18, 2024 Via ACCESSWIRE Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024 May 29, 2024 Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and... Via Newsfile Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024 April 03, 2024 Via ACCESSWIRE Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023 November 30, 2023 Via ACCESSWIRE Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results November 14, 2023 Via ACCESSWIRE Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 May 23, 2024 Via ACCESSWIRE Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024 May 08, 2024 Via ACCESSWIRE Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter February 14, 2024 Via ACCESSWIRE Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024 February 07, 2024 Via ACCESSWIRE Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024 January 23, 2024 Via ACCESSWIRE Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year November 08, 2023 Via ACCESSWIRE Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement October 26, 2023 Via ACCESSWIRE Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28 September 28, 2023 Via Investor Brand Network Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023 November 07, 2023 Via ACCESSWIRE Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023 October 09, 2023 Via ACCESSWIRE Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023 September 26, 2023 Via ACCESSWIRE Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023 September 21, 2023 Via ACCESSWIRE Aytu BioPharma to Present at LD Micro Main Event XVI Conference September 13, 2023 Via ACCESSWIRE Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market June 13, 2023 Via ACCESSWIRE Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline August 08, 2023 Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the... Via Newsfile Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority July 31, 2023 Via ACCESSWIRE Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement July 10, 2023 Via ACCESSWIRE Aytu to Participate in the Maxim Group Virtual Healthcare Conference June 14, 2023 Via ACCESSWIRE Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director June 09, 2023 Via ACCESSWIRE Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results May 11, 2023 Via ACCESSWIRE Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023 May 04, 2023 Via ACCESSWIRE Aytu BioPharma Subleases a Portion of Its Manufacturing Facility May 01, 2023 Via ACCESSWIRE < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.